Stock listing
OTC:KYKOF Kyowa Kirin Co., Ltd. Stock
US listing (OTC) of Kyowa Kirin Co., Ltd. · home listing Tokyo:4151
Follow Kyowa Kirin Co., Ltd. into a list and get an email when it puts out news.
Share price · OTC:KYKOF
$16.62 USD -0.13 (-0.8%)
Close on Nov 17, 2026
- Day range
- $16.62 – $16.62 USDNov 17, 2026
- Volume
- 201 sharesNov 17, 2026
- Market cap
- $8.70B USDAt the close on Nov 17, 2026 · price × 523.6M shares outstanding
- Traded on an average day
- $146,460 USDMedian day 1,388 shares · last 3 months, Sep 2, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:KYKOF | $16.62 USD | -0.134 (-0.8%) | 201 | $16.62 | $16.62 | $16.62 | $16.75 | Close on Nov 17, 2026 |
| OTC:KYKOY | $16.30 USD | +0.10 (+0.6%) | 100 | $16.30 | $16.30 | $16.30 | $16.20 | Close on Nov 17, 2026 |
| Dusseldorf:KY4 | €14.40 EUR | -0.20 (-1.4%) | — | €14.40 | €14.50 | €14.40 | €14.60 | Close on Nov 17, 2026 |
| Frankfurt:KY4 | €14.70 EUR | +0.20 (+1.4%) | — | €14.70 | €14.70 | €14.70 | €14.50 | Close on Nov 16, 2026 |
| Munich:KY4 | €14.70 EUR | 0.00 (0.0%) | — | €14.70 | €14.70 | €14.70 | €14.70 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Sep 2, 2026 – Nov 6, 2026 · OTC:KYKOF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $15.51 | -0.624 | -3.9% | $15.28 | $15.51 | $15.28 | 4,900 | |
| $16.13 | +0.334 | +2.1% | $16.97 | $16.97 | $16.13 | 1,700 | |
| $15.80 | 0.00 | 0.0% | $15.99 | $15.99 | $15.80 | 700 | |
| $15.80 | -0.12 | -0.8% | $17.07 | $17.07 | $15.64 | 1,400 | |
| $15.92 | -0.832 | -5.0% | $16.82 | $16.82 | $15.92 | 1,600 | |
| $16.75 | +1.352 | +8.8% | $16.75 | $16.75 | $16.75 | 300 | |
| $15.40 | -0.10 | -0.6% | $16.35 | $16.35 | $15.40 | 358 | |
| $15.50 | -0.25 | -1.6% | $15.50 | $15.50 | $15.50 | 1,388 | |
| $15.75 | +0.25 | +1.6% | $15.75 | $15.75 | $15.75 | 300 | |
| $15.50 | +0.19 | +1.2% | $15.50 | $15.50 | $15.50 | 333 | |
| $15.31 | +0.42 | +2.8% | $16.17 | $16.17 | $15.31 | 883 | |
| $14.89 | -1.26 | -7.8% | $15.66 | $15.66 | $14.89 | 2,249 | |
| $16.15 | +1.75 | +12.2% | $16.15 | $16.15 | $16.15 | 201 | |
| $14.40 | +0.28 | +2.0% | $14.40 | $14.40 | $14.40 | 240 | |
| $14.12 | +0.22 | +1.6% | $13.14 | $14.30 | $13.14 | 1,977 | |
| $13.90 | -0.20 | -1.4% | $13.63 | $13.90 | $13.63 | 754 | |
| $14.10 | -0.10 | -0.7% | $14.75 | $14.75 | $14.10 | 1,468 | |
| $14.20 | +0.205 | +1.5% | $14.93 | $14.93 | $4.20 | 632 | |
| $14.00 | -0.055 | -0.4% | $14.00 | $14.00 | $14.00 | 4,724 | |
| $14.05 | -0.66 | -4.5% | $15.22 | $15.22 | $13.38 | 1,644 | |
| $14.71 | +0.26 | +1.8% | $13.71 | $15.35 | $13.71 | 1,780 | |
| $14.45 | -0.10 | -0.7% | $14.45 | $14.45 | $14.45 | 342 | |
| $14.55 | -0.15 | -1.0% | $14.38 | $14.55 | $14.38 | 1,653 | |
| $14.70 | +0.30 | +2.1% | $14.31 | $15.90 | $14.31 | 212,980 | |
| $14.40 | -0.10 | -0.7% | $15.51 | $15.51 | $14.40 | 1,294 | |
| $14.50 | -1.30 | -8.2% | $14.60 | $14.60 | $14.50 | 22,981 | |
| $15.80 | — | — | $15.80 | $15.80 | $15.80 | 100 |
- Ticker
- OTC:KYKOF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Consolidated Financial Summary (IFRS) Fiscal 2026 Third Quarter
Latest deck · November 2026
Q3 2026 Earnings Presentation
Earnings · 47 slides
Latest news
Consolidated Financial Summary (IFRS) Fiscal 2026 Third Quarter
Nov 2, 2026
Closed $15.92 (-5.0%) on Nov 2, 2026
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2026 Third Quarter
Nov 2, 2026
Closed $15.92 (-5.0%) on Nov 2, 2026
Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo®) in Patients With Mycosis Fungoides and Sézary Syndrome
Oct 12, 2026
Closed $14.12 (+1.6%) on Oct 13, 2026
Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America
Sep 29, 2026
Closed $14.71 (+1.8%) on Sep 30, 2026
Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans
Aug 31, 2026
Closed $15.80 (+9.5%) on Sep 2, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 47 slides · November 2026
Q2 2026 Earnings Presentation
Earnings · 47 slides · Sep 16, 2026
Q1 2026 Earnings Presentation
Earnings · 44 slides · Sep 16, 2026
Technical Presentation (September 2026)
Technical · 16 slides · Sep 9, 2026
Kyowa Kirin Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 32 in the last 12 months · 50 in all · newest Nov 2, 2026 · oldest 2025
- Decks
- 154 decks · latest November 2026
Where Kyowa Kirin Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4151 協和キリン · Home listing | Tokyo | Japan | JPY |
| OTC:KYKOF · This page | OTC | United States | USD |
| gettex:KY4 | gettex | Germany | EUR |
| LS Exchange:858523 | LS Exchange | Germany | EUR |
| Lang & Schwarz:858523 | Lang & Schwarz | Germany | EUR |
| OTC:KYKOY | OTC | United States | USD |
| Stuttgart:KY4 | Stuttgart | Germany | EUR |
| Dusseldorf:KY4 | Dusseldorf | Germany | EUR |
| Frankfurt:KY4 | Frankfurt | Germany | EUR |
| Hanover:KY4 | Hanover | Germany | EUR |
| Munich:KY4 | Munich | Germany | EUR |
| Tradegate:KY4 | Tradegate | Germany | EUR |
| Hamburg:KY4 | Hamburg | Germany | EUR |
Log in to ask 6ix AI your own questions about Kyowa Kirin Co., Ltd.